These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22092642)

  • 21. Hepatocellular necrosis with prominent regenerative reactions in a zonisamide administrated dog.
    Takami Y; Izawa T; Tanaka M; Hatoya S; Nabetani T; Yamate J; Kuwamura M
    J Vet Med Sci; 2020 Jun; 82(6):704-706. PubMed ID: 32249255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Othello syndrome secondary to zonisamide].
    Rubio-Nazabal E; Alvarez-Pérez P; Lema-Facal T; López-Facal S
    Med Clin (Barc); 2014 Feb; 142(3):133-4. PubMed ID: 23664689
    [No Abstract]   [Full Text] [Related]  

  • 23. Zonisamide-induced suicidal ideation.
    Mago R; Huege S; Ahuja N; Kunkel EJ
    Psychosomatics; 2006; 47(1):68-9. PubMed ID: 16384810
    [No Abstract]   [Full Text] [Related]  

  • 24. Topiramate-Associated Renal Tubular Acidosis.
    Parthvi R; Mehra S
    Am J Ther; 2018; 25(6):e772-e773. PubMed ID: 29782342
    [No Abstract]   [Full Text] [Related]  

  • 25. Continued use of zonisamide following development of renal calculi.
    Richards KC; Smith MC; Verma A
    Neurology; 2005 Feb; 64(4):763-4. PubMed ID: 15728320
    [No Abstract]   [Full Text] [Related]  

  • 26. Zonisamide.
    Seino M; Miyazaki H; Ito T
    Epilepsy Res Suppl; 1991; 3():169-74. PubMed ID: 1777076
    [No Abstract]   [Full Text] [Related]  

  • 27. Zonisamide-induced restless legs syndrome.
    Chen JT; Garcia PA; Alldredge BK
    Neurology; 2003 Jan; 60(1):147. PubMed ID: 12525743
    [No Abstract]   [Full Text] [Related]  

  • 28. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.
    Baulac M; Patten A; Giorgi L
    Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zonisamide suppresses the tonic phase but not the clonic phase of generalized seizures in developing rats.
    Mareš P
    Epilepsy Res; 2010 Dec; 92(2-3):244-8. PubMed ID: 20947303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.
    Baulac M; Leppik IE
    Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zonisamide approved for partial seizures.
    Am J Health Syst Pharm; 2000 May; 57(9):834, 837. PubMed ID: 10840516
    [No Abstract]   [Full Text] [Related]  

  • 33. Neutropenia and thrombocytopenia in three dogs treated with anticonvulsants.
    Jacobs G; Calvert C; Kaufman A
    J Am Vet Med Assoc; 1998 Mar; 212(5):681-4. PubMed ID: 9524640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune-mediated polyarthritis and anterior uveitis secondary to zonisamide administration in a dog with refractory epilepsy.
    Baya P; Press S; Istvan S; Rizzo K
    Vet Med Sci; 2024 Mar; 10(2):e1374. PubMed ID: 38403976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Topiramate-induced renal tubular acidosis. A case report].
    Sujan S; Torres de Rueda A; Montero L; Toledo R; Ros S; Martín Reyes G
    Nefrologia; 2008; 28(6):656-7. PubMed ID: 19016644
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuroleptic malignant syndrome-like state in an epileptic patient with organic brain comorbidity treated with zonisamide and carbamazepine.
    Azuma H; Negi A; Hattori M; Masayasu T; Akechi T; Furukawa TA
    Epilepsia; 2007 Oct; 48(10):1999-2001. PubMed ID: 17922775
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of zonisamide on serum immunoglobulins.
    Fujimoto Y; Ikoma R; Shimizu T; Shimizu A
    Arzneimittelforschung; 1990 Aug; 40(8):855-8. PubMed ID: 2242076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zonisamide for seizures in Parkinson's disease with dementia.
    Tombini M; Pellegrino G; Di Pino G; Assenza G
    Seizure; 2013 May; 22(4):324-5. PubMed ID: 23403093
    [No Abstract]   [Full Text] [Related]  

  • 39. Topiramate induces type 3 renal tubular acidosis by inhibiting renal carbonic anhydrase.
    Sacré A; Jouret F; Manicourt D; Devuyst O
    Nephrol Dial Transplant; 2006 Oct; 21(10):2995-6. PubMed ID: 16735391
    [No Abstract]   [Full Text] [Related]  

  • 40. Zonisamide in the management of epilepsy--Japanese experience.
    Ohtahara S
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.